SOURCE: Novus Acquisition & Development Corp

September 10, 2014 08:00 ET

Novus Enters Into Exclusive Agreement With TKO Organics to Provide Medical Marijuana & Fulfillment Services to MedPlan Patients

MIAMI, FL--(Marketwired - Sep 10, 2014) - Novus Acquisition & Development Corp. (PINKSHEETS: NDEV) ("Novus"), a provider of health insurance and insurance-related services under the "MedPlan" brand through its subsidiary Novus Medical Group, Inc., today announced an agreement with TKO Reserve, LLC aka Turnkey Organics LLC. "TKO" to act as a third-party administrator of Novus' MedPlan, handling quality control, order processing, and delivery coordination to patients in Washington, Arizona, Oregon, California, Colorado, Nevada and Michigan.

"Finding suppliers is a big challenge in this industry," said Novus Acquisition & Development Corp. CEO Frank Labrozzi. "The TKO Organics' products stand out from a market that is flooded by entrepreneurs growing mediocre strains using subpar techniques. Quality control and standardization is the key, while this agreement provides the company with an adequate supply of medical marijuana for its growing number of MedPlan patients."

TKO Organics is a fully-operational indoor organic medical cannabis growing and production facility in compliance with the Washington State Medical Use of Marijuana Act (RCW69.51A). By leveraging cutting-edge indoor growing technology and proprietary extraction techniques, the company will help standardize products for Novus' MMJ patients with optimal cannabinoid ratios and other beneficial characteristics. The extraction techniques and new genetic varieties pioneered by the TKO will provide Novus' patients with medicine that has been known to aid in treating or relieving debilitating medical conditions. In a testament to its growing line-up of high quality products, TKO recently won second place at the High Times Seattle Cannabis Cup for their Slips product that they produce via a joint venture with Oakor.

 Under the exclusive agreement, TKO Organics will work as an outsourced administrative arm for Novus Medical Group, handling quality control, delivery coordination, distribution to dispensaries, and providing a user-friendly ordering process to Novus MedPlan patients in Washington, Arizona, Oregon, California, Colorado Nevada and Michigan.

About Novus

Novus Acquisition & Development Corp. ("Novus") provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians' education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

About TKO Organics LLC

TKO is one of Seattle's premier growers of medical marijuana, gaining fast recognition as a specialty grower of specialist in varieties including rare and exotic strains, as well as CBD rich strains. TKO growers are biodynamic farmers who combine years of horticultural and botanical research with state-of-the-art resources to increase plant potency and yield by replicating seasonal estimates of our strain's natural environment. Using only the finest, local organic nutrients and zero particle water, TKO products are clean and pure with consistency in flavor, appearance and potency.

The company's mission is to provide patients with true organic medicine, education about cannabis, and compassionate care. We are able to accomplish our mission through our knowledge of product, dedication to customer satisfaction, maintaining quality, and always striving for excellence. Using our proprietary techniques, we are able to produce organic medicine in quantities that rival synthetic crop production. While synthetic crop production isn't necessarily bad, organic cannabis has more beneficial cannabinoid properties and a wider range of flavonoids and terpenes. These are hugely beneficial for medical use, and are pivotal in making us unique in the marketplace.

Safe Harbor;
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information